Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, G-Protein-Coupled | 15 | 2019 | 137 | 4.580 |
Why?
|
| Estrogens | 14 | 2020 | 200 | 3.240 |
Why?
|
| Chymases | 10 | 2020 | 76 | 3.060 |
Why?
|
| Ventricular Remodeling | 9 | 2020 | 92 | 2.740 |
Why?
|
| Ventricular Dysfunction, Left | 8 | 2019 | 192 | 2.730 |
Why?
|
| Myocytes, Cardiac | 4 | 2019 | 107 | 2.430 |
Why?
|
| Ovariectomy | 12 | 2019 | 178 | 2.180 |
Why?
|
| Receptors, Estrogen | 5 | 2019 | 108 | 2.160 |
Why?
|
| Myocardium | 11 | 2019 | 241 | 1.950 |
Why?
|
| Heart Ventricles | 4 | 2020 | 144 | 1.500 |
Why?
|
| Diastole | 10 | 2019 | 145 | 1.480 |
Why?
|
| Angiotensin II | 9 | 2019 | 382 | 1.420 |
Why?
|
| Ventricular Function, Left | 6 | 2019 | 259 | 1.370 |
Why?
|
| Angiotensinogen | 5 | 2020 | 119 | 1.240 |
Why?
|
| Peptide Fragments | 5 | 2020 | 519 | 1.080 |
Why?
|
| Renin-Angiotensin System | 7 | 2019 | 267 | 1.050 |
Why?
|
| Animals | 28 | 2020 | 7552 | 1.020 |
Why?
|
| Heart Atria | 2 | 2020 | 75 | 0.940 |
Why?
|
| Mast Cells | 3 | 2016 | 33 | 0.930 |
Why?
|
| Atrial Appendage | 1 | 2021 | 10 | 0.900 |
Why?
|
| Gene Deletion | 2 | 2019 | 74 | 0.850 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 74 | 0.850 |
Why?
|
| Rats | 16 | 2019 | 1750 | 0.830 |
Why?
|
| Cyclopentanes | 4 | 2019 | 27 | 0.820 |
Why?
|
| Cardiotonic Agents | 3 | 2018 | 59 | 0.820 |
Why?
|
| Quinolines | 4 | 2019 | 37 | 0.810 |
Why?
|
| Furans | 1 | 2019 | 4 | 0.800 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 492 | 0.780 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2019 | 101 | 0.780 |
Why?
|
| Sulfonamides | 1 | 2019 | 72 | 0.760 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 346 | 0.760 |
Why?
|
| Muscle Proteins | 1 | 2019 | 63 | 0.760 |
Why?
|
| Oxidative Stress | 3 | 2018 | 259 | 0.750 |
Why?
|
| Renin | 4 | 2013 | 164 | 0.700 |
Why?
|
| Heart | 6 | 2019 | 206 | 0.700 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2016 | 122 | 0.690 |
Why?
|
| Cromolyn Sodium | 1 | 2016 | 5 | 0.660 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 318 | 0.650 |
Why?
|
| Physical Conditioning, Animal | 1 | 2016 | 39 | 0.630 |
Why?
|
| Female | 23 | 2020 | 18970 | 0.610 |
Why?
|
| Muscle Strength | 1 | 2016 | 134 | 0.600 |
Why?
|
| Muscle, Skeletal | 2 | 2018 | 493 | 0.590 |
Why?
|
| RNA, Messenger | 5 | 2020 | 544 | 0.580 |
Why?
|
| Stroke | 1 | 2020 | 545 | 0.570 |
Why?
|
| Fibroblasts | 1 | 2015 | 117 | 0.560 |
Why?
|
| Peptidyl-Dipeptidase A | 4 | 2020 | 203 | 0.540 |
Why?
|
| Mice | 6 | 2019 | 2366 | 0.520 |
Why?
|
| Cell Proliferation | 2 | 2015 | 603 | 0.520 |
Why?
|
| Rats, Inbred SHR | 5 | 2019 | 71 | 0.510 |
Why?
|
| Mice, Knockout | 3 | 2019 | 429 | 0.490 |
Why?
|
| Rats, Inbred Lew | 7 | 2015 | 146 | 0.400 |
Why?
|
| Rats, Inbred BN | 4 | 2016 | 43 | 0.390 |
Why?
|
| Receptor, Angiotensin, Type 1 | 4 | 2019 | 110 | 0.390 |
Why?
|
| Rats, Inbred F344 | 4 | 2016 | 137 | 0.380 |
Why?
|
| Hypertension | 5 | 2019 | 994 | 0.370 |
Why?
|
| Immunohistochemistry | 3 | 2020 | 502 | 0.330 |
Why?
|
| Heart Failure | 3 | 2017 | 662 | 0.320 |
Why?
|
| Collagen | 3 | 2018 | 232 | 0.310 |
Why?
|
| Disease Models, Animal | 8 | 2019 | 1040 | 0.310 |
Why?
|
| Blood Pressure | 4 | 2016 | 910 | 0.290 |
Why?
|
| Cell Line | 3 | 2016 | 432 | 0.290 |
Why?
|
| Estradiol | 3 | 2015 | 130 | 0.290 |
Why?
|
| Gene Expression | 2 | 2018 | 340 | 0.280 |
Why?
|
| Rats, Transgenic | 3 | 2013 | 80 | 0.280 |
Why?
|
| Male | 11 | 2020 | 18658 | 0.280 |
Why?
|
| Echocardiography | 3 | 2020 | 160 | 0.260 |
Why?
|
| Up-Regulation | 3 | 2019 | 206 | 0.260 |
Why?
|
| Heart Valve Diseases | 2 | 2020 | 32 | 0.250 |
Why?
|
| Rats, Inbred WKY | 2 | 2019 | 36 | 0.240 |
Why?
|
| Myocardial Ischemia | 2 | 2020 | 93 | 0.240 |
Why?
|
| Angiotensin I | 2 | 2015 | 342 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2019 | 121 | 0.220 |
Why?
|
| Angiotensins | 1 | 2021 | 68 | 0.220 |
Why?
|
| Organ Size | 2 | 2018 | 220 | 0.220 |
Why?
|
| Hypertension, Pulmonary | 2 | 2018 | 28 | 0.210 |
Why?
|
| Sex Factors | 2 | 2020 | 699 | 0.210 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2019 | 23 | 0.210 |
Why?
|
| Time Factors | 3 | 2016 | 2105 | 0.210 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 162 | 0.200 |
Why?
|
| Bone Marrow | 1 | 2019 | 59 | 0.200 |
Why?
|
| Myeloid Cells | 1 | 2019 | 41 | 0.200 |
Why?
|
| Aging | 2 | 2021 | 930 | 0.200 |
Why?
|
| Antigens, CD | 1 | 2019 | 102 | 0.200 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 65 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 71 | 0.200 |
Why?
|
| Random Allocation | 3 | 2016 | 229 | 0.190 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 65 | 0.190 |
Why?
|
| Ventricular Dysfunction | 1 | 2018 | 6 | 0.190 |
Why?
|
| CDC2 Protein Kinase | 2 | 2015 | 6 | 0.190 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2015 | 14 | 0.190 |
Why?
|
| Aldehydes | 1 | 2018 | 6 | 0.190 |
Why?
|
| Deoxyguanosine | 1 | 2018 | 7 | 0.190 |
Why?
|
| Ubiquinone | 1 | 2018 | 9 | 0.190 |
Why?
|
| Glutathione | 1 | 2018 | 42 | 0.180 |
Why?
|
| Organophosphorus Compounds | 1 | 2018 | 43 | 0.180 |
Why?
|
| Age Factors | 3 | 2016 | 1185 | 0.180 |
Why?
|
| Aged | 3 | 2021 | 10068 | 0.180 |
Why?
|
| Antioxidants | 1 | 2018 | 113 | 0.170 |
Why?
|
| Hydrazones | 1 | 2017 | 11 | 0.170 |
Why?
|
| Thiophenes | 1 | 2017 | 23 | 0.170 |
Why?
|
| Exercise Tolerance | 1 | 2018 | 130 | 0.170 |
Why?
|
| Infusions, Subcutaneous | 1 | 2016 | 9 | 0.170 |
Why?
|
| Ventricular Pressure | 1 | 2016 | 15 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 813 | 0.160 |
Why?
|
| Crosses, Genetic | 1 | 2016 | 28 | 0.160 |
Why?
|
| Heat-Shock Proteins | 1 | 2016 | 27 | 0.160 |
Why?
|
| Fibrosis | 1 | 2016 | 117 | 0.160 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 162 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 254 | 0.150 |
Why?
|
| Muscle Contraction | 1 | 2016 | 111 | 0.150 |
Why?
|
| Cyclin B1 | 1 | 2015 | 2 | 0.150 |
Why?
|
| Vimentin | 1 | 2015 | 12 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2016 | 175 | 0.150 |
Why?
|
| Exercise Test | 1 | 2016 | 202 | 0.150 |
Why?
|
| Biopterin | 2 | 2013 | 7 | 0.150 |
Why?
|
| Ki-67 Antigen | 1 | 2015 | 30 | 0.150 |
Why?
|
| Echocardiography, Doppler | 2 | 2012 | 50 | 0.150 |
Why?
|
| Nitric Oxide Synthase | 2 | 2014 | 40 | 0.150 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 57 | 0.150 |
Why?
|
| Humans | 8 | 2021 | 29292 | 0.140 |
Why?
|
| Nitric Oxide | 2 | 2013 | 127 | 0.140 |
Why?
|
| Calcium | 2 | 2017 | 322 | 0.140 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 39 | 0.140 |
Why?
|
| Apoptosis | 1 | 2016 | 369 | 0.130 |
Why?
|
| Antihypertensive Agents | 2 | 2016 | 379 | 0.130 |
Why?
|
| Valine | 1 | 2012 | 29 | 0.130 |
Why?
|
| Fumarates | 1 | 2012 | 14 | 0.130 |
Why?
|
| Blotting, Western | 1 | 2013 | 281 | 0.130 |
Why?
|
| Amides | 1 | 2012 | 38 | 0.130 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 485 | 0.120 |
Why?
|
| Postmenopause | 2 | 2014 | 414 | 0.120 |
Why?
|
| Heart Rate | 2 | 2012 | 358 | 0.120 |
Why?
|
| Tetrazoles | 1 | 2012 | 101 | 0.120 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2012 | 17 | 0.120 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 37 | 0.120 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2012 | 108 | 0.120 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2012 | 63 | 0.120 |
Why?
|
| Enalapril | 1 | 2011 | 13 | 0.120 |
Why?
|
| Ornithine | 1 | 2011 | 7 | 0.120 |
Why?
|
| Superoxides | 1 | 2011 | 19 | 0.110 |
Why?
|
| Heart Failure, Diastolic | 1 | 2011 | 21 | 0.110 |
Why?
|
| Losartan | 1 | 2011 | 89 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 162 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2011 | 112 | 0.100 |
Why?
|
| Phenotype | 1 | 2012 | 666 | 0.100 |
Why?
|
| Genotype | 1 | 2012 | 839 | 0.100 |
Why?
|
| Middle Aged | 2 | 2020 | 11572 | 0.090 |
Why?
|
| Hemodynamics | 2 | 2017 | 180 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2019 | 743 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 674 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 20 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2019 | 67 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 66 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2019 | 173 | 0.050 |
Why?
|
| Models, Animal | 1 | 2019 | 168 | 0.050 |
Why?
|
| Monocrotaline | 1 | 2018 | 4 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 24 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2019 | 793 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2016 | 92 | 0.040 |
Why?
|
| Receptors, Angiotensin | 1 | 2017 | 90 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2017 | 180 | 0.040 |
Why?
|
| Body Weight | 1 | 2017 | 305 | 0.040 |
Why?
|
| Telemetry | 1 | 2012 | 35 | 0.030 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2014 | 189 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 303 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2011 | 9 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2011 | 20 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2014 | 388 | 0.030 |
Why?
|
| Reference Values | 1 | 2011 | 245 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 99 | 0.030 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2010 | 35 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 2010 | 41 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 275 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2011 | 491 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 537 | 0.030 |
Why?
|
| Kidney | 1 | 2012 | 481 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 3732 | 0.020 |
Why?
|